UACA 抗体 (AA 311-410) (AbBy Fluor® 350)
-
- 抗原 See all UACA 抗体
- UACA
-
抗原表位
- AA 311-410
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This UACA antibody is conjugated to AbBy Fluor® 350
-
应用范围
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 预测反应
- Human,Mouse,Rat,Cow,Horse,Rabbit
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human UACA
- 亚型
- IgG
- Top Product
- Discover our top product UACA Primary Antibody
-
anti-UACA (UACA) (AA 29-209) antibody
UACA 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-UACA (UACA) (AA 1-90) antibodyUACA 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-UACA (UACA) antibodyUACA 适用: 人, 小鼠 IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-UACA (UACA) (AA 1309-1358) antibodyUACA 适用: 人, 小鼠, Cow, 犬, 豚鼠, 马, 猴, Pig WB 宿主: 兔 Polyclonal unconjugated
anti-UACA (UACA) (AA 1-1416) antibodyUACA 适用: 人 WB 宿主: 小鼠 Polyclonal unconjugated
anti-UACA (UACA) antibodyUACA 适用: 人, 小鼠 WB, IF, FACS 宿主: 小鼠 Monoclonal AE-5 unconjugated
-
- 应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- UACA
- 别名
- UACA (UACA 产品)
- 别名
- NUCLING antibody, 2700059D02Rik antibody, nucling antibody, RGD1560011 antibody, uveal autoantigen with coiled-coil domains and ankyrin repeats antibody, UACA antibody, Uaca antibody
- 背景
-
Synonyms: NUCLING, Uveal autoantigen with coiled-coil domains and ankyrin repeats, UACA, KIAA1561
Background: Regulates APAF1 expression and plays an important role in the regulation of stress-induced apoptosis. Promotes apoptosis by regulating three pathways, apoptosome up-regulation, LGALS3/galectin-3 down-regulation and NF-kappa-B inactivation. Regulates the redistribution of APAF1 into the nucleus after proapoptotic stress. Down-regulates the expression of LGALS3 by inhibiting NFKB1 (By similarity). Modulates isoactin dynamics to regulate the morphological alterations required for cell growth and motility. Interaction with ARF6 may modulate cell shape and motility after injury (By similarity).
- 基因ID
- 55075
- UniProt
- Q9BZF9
- 途径
- Positive Regulation of Endopeptidase Activity
-
